Eric Therrien is a renowned Director of Computational Chemistry at ³§³¦³ó°ùö»å¾±²Ô²µ±ð°ù, where leadership spans collaborative and internal discovery programs in oncology, immunology, and neurology since September 2016. Prior roles include Senior Principal Scientist at ³§³¦³ó°ùö»å¾±²Ô²µ±ð°ù, contributing to significant discoveries such as KAI-11101 and various inhibitors targeting cancer-related pathways. Also, Eric co-founded Molecular Forecaster, a McGill University spin-off, and served as a Research Scientist at IntelliSyn R&D, focusing on structure-based synthesis of enzyme inhibitors. Experience includes senior roles in developing kinase inhibitors at Laboratoires ChemRF and research positions at McGill University and MethylGene Inc., with a PhD in Organic Chemistry from Université de Montréal.
This person is not in any teams
This person is not in any offices